Viet Le, MPAS PA-C FACC FAHAStopping in to congratulate @shelbyK88 and Michelle Lim PA-C on @EsperionInc #ClearOutcomes Trial.
Why we #acc23. Celebrate successes for therapeutics
#clearoutcomes
🫀subgroups - yay benefit in women
🫀benefit seen in 1° 👀👍🏾 as well as 2°
🫀benefit in diabetes 🙌🏾🙌🏾
Important CVOT adding #BempedoicAcid into the hall of MACE reducing #LLT.
#acc23 #HeartPA #PhysicianAssociate
#clearoutcomes
🫀N~14k, 70% 2°, 30% 1°
🫀~22%ish ⬇️LDL-C and ⬇️hsCRP
🫀RRR 13% 1° MACE endpt
🫀RRR 15% 3-pt MACE
#acc23
🫀N~14k, 70% 2°, 30% 1°
🫀~22%ish ⬇️LDL-C and ⬇️hsCRP
🫀RRR 13% 1° MACE endpt
🫀RRR 15% 3-pt MACE
#acc23
#clearoutcomes what will we find out?
🫀up to 20% reported statin intolerance (choice not to use)
🫀prodrug - activated in liver, low to no peripheral tissue effect (⬇️mm aches)
🫀4pt- 3pt- MACE
🫀1°&2° populations
#acc23
🫀up to 20% reported statin intolerance (choice not to use)
🫀prodrug - activated in liver, low to no peripheral tissue effect (⬇️mm aches)
🫀4pt- 3pt- MACE
🫀1°&2° populations
#acc23
Wow. Folks truly want to hear the #LBCT #ClearOutcomes bempedoic acid this am!!!